抄録
Poly (DL-lactic acid), irinotecan and polyethylene glycol monostearate were dissolved in acetone, and copre-cipitated by the addition of water. Then, the organic solvent was evaporated. The nanoparticle-containing suspension (NP-S) obtained by that coprecipitation was characterized both in vitro and in vivo. The nanoparticles showed a mean diameter of 150nm with its distribution of 110 to 270nm. At least 20% (w / w) of the drug was incorporated in the nanoparticles. These particle characteristics of NP-S were reproducibly obtained. When the antitumor effect was examined by the i.v. administration at repeated doses of 20mg irinotecan eq. / kg / day for 3 days (20×3 mg irinotecan eq. / kg) using mice bearing sarcoma 180 subcutaneously, NP-S was found to be sig-nificantly effective and it also tended to show a better suppression of tumor growth than an irinotecan hydrochloride (CPT-11) aqueous solution. After i.v. injections in rats, NP-S retained the plasma concentration of irinotecan longer than a CPT-11 aqueous solution. These findings suggest that NP-S may possibly improve the action of irinotecan against solid tumors.
